Delivery Order SPE2DB20D3104-SPE2DB24FV9E2

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,656.25 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order valued at $1,831.07 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product "LOW-OGESTREL-28 TABLET 28S". The award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.36 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,431.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,562,215,800 units of the low-dosage oral contraceptive "LOW-OGESTREL-28 TABLET 28S." This contract has an ultimate completion date of September 19, 2023. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC) valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,345.96, is for the supply of Low-Ogestrel-28 Tablet 28s, a prescription contraceptive medication. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of the medication LOW-OGESTREL-28 TABLET 28S, a firm fixed price order valued at $4,211.28. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.84 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a completion date of July 15, 2024. The award is not designated as a set-aside contract. It is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company. The contract, valued at $1,483.62, is for the delivery of 4564404760 LOW-OGESTREL-28 TABLET 28S, a prescription medication. The contract does not have a set-aside designation and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major supplier of pharmaceutical...
This federal contract award, valued at $2,303.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. This is a firm fixed price delivery order contract with a period of performance ending on February 21, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award, with an ID of SPE2DX15D7057|SPE2DX23FLBFV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,505.36 firm fixed price delivery order is for the pharmaceutical product "LOW-OGESTREL-28 TABLET 28S" and has an ultimate completion date of September 26, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9E2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,422.60 firm fixed-price contract is for the delivery of LOW-OGESTREL-28 TABLET 28S, a generic pharmaceutical product. The award has an ultimate completion date of September 5, 2024.

AmerisourceBergen holds a larger, $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that broader IDC agreement. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:50 AM